PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30700011-0	2019	Hypolipogenic Effect of Shikimic Acid Via Inhibition of MID1IP1 and Phosphorylation of AMPK/ACC.	Shikimic Acid	24-37	protein kinase AMP-activated catalytic subunit alpha 1	Homo sapiens	87-91	
30700011-5	2019	It should be noted that shikimic acid activated phosphorylation of AMP-activated protein kinase (AMPK)/Aacetyl-coenzyme A carboxylase (ACC) and reduced the expression of MID1 Interacting Protein 1 (MID1IP1) in HepG2, Huh7 and 3T3-L1 cells.	Shikimic Acid	24-37	protein kinase AMP-activated catalytic subunit alpha 1	Homo sapiens	67-95	
30700011-5	2019	It should be noted that shikimic acid activated phosphorylation of AMP-activated protein kinase (AMPK)/Aacetyl-coenzyme A carboxylase (ACC) and reduced the expression of MID1 Interacting Protein 1 (MID1IP1) in HepG2, Huh7 and 3T3-L1 cells.	Shikimic Acid	24-37	protein kinase AMP-activated catalytic subunit alpha 1	Homo sapiens	97-101	
30700011-8	2019	Taken together, our findings suggest that shikimic acid has hypolipogenic effect in HepG2 and 3T3-L1 cells via phosphorylation of AMPK/ACC and inhibition of MID1IP1 as a potent candidate for prevention or treatment of fatty liver and hyperlipidemia.	Shikimic Acid	42-55	protein kinase AMP-activated catalytic subunit alpha 1	Homo sapiens	130-134